Ignite Creation Date:
2024-05-05 @ 5:32 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00476853
Status:
COMPLETED
Last Update Posted:
2020-07-17
First Post:
2007-05-20
Brief Title:
Efficacy Safety Study Comparing 2 Doses of NVP After Initiating Rifampin-containing TB Therapy
Sponsor:
The HIV Netherlands Australia Thailand Research Collaboration
Organization:
The HIV Netherlands Australia Thailand Research Collaboration
Organization Data
Organization:
The HIV Netherlands Australia Thailand Research Collaboration
Class:
OTHER
Study ID:
HIV-NAT 033
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
The HIV Netherlands Australia Thailand Research Collaboration
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| The Research Institute of Tuberculosis Japan | UNKNOWN |
| other sponsorsJapanese MOPH | UNKNOWN |
| Labor and Welfare | UNKNOWN |
| Thai MOPH | UNKNOWN |
| Thai GPO | UNKNOWN |
| Bamrasnaradura Infectious Diseases Institute | OTHER_GOV |
| Chiang Rai Hospital | OTHER |
| King Chulalongkorn Memorial Hospital | OTHER |
| Central General Chest Institute | UNKNOWN |